Trials / Completed
CompletedNCT00817245
Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)
Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tabriz University · Academic / Other
- Sex
- All
- Age
- 28 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.
Detailed description
we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | omeprazole, Amoxicillin, metronidazole | we will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-10-01
- Completion
- 2009-01-01
- First posted
- 2009-01-06
- Last updated
- 2009-01-06
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00817245. Inclusion in this directory is not an endorsement.